

Saltigo has signed an agreement with Tokyo-based Daiichi Sankyo for the provision of contract manufacturing services; this comes ahead of Daiichi Sankyo's plans to commercialize one of its novel drug pipeline projects.
Saltigo, the custom manufacturing business of Lanxess' Advanced Intermediates segment, which achieved total sales of €1.5 billion in 2011, has realigned its strategy.